Sp126

EARLY DETECTION OF PANCREATIC CANCER

Date
May 18, 2024

Presenter

Speaker Image for Shounak Majumder
Mayo Clinic Minnesota

Tracks

Related Products

Thumbnail for QUESTION AND ANSWER
QUESTION AND ANSWER
Session will review the diagnosis and treatment of autoimmune pancreatitis…
Thumbnail for MOLECULAR DETECTION OF PANCREATIC NEUROENDOCRINE TUMORS USING PLASMA METHYLATED DNA MARKERS
MOLECULAR DETECTION OF PANCREATIC NEUROENDOCRINE TUMORS USING PLASMA METHYLATED DNA MARKERS
BACKGROUND: Colonic polyposis, which is a risk factor for colorectal cancer (CRC), can be driven by a pathogenic variant in a polyposis gene. However, in many cases germline genetic testing is negative, leaving the cause of the polyposis unknown…
Thumbnail for METHYLATED DNA BIOMARKERS IN PANCREATIC JUICE FOR PANCREATIC CANCER DETECTION
METHYLATED DNA BIOMARKERS IN PANCREATIC JUICE FOR PANCREATIC CANCER DETECTION
A translational symposium that focuses on the evolving role of artificial intelligence and machine learning in early detection of pancreatic cancer, genetic testing and novel molecular diagnostic bio-markers and recent advances in digital tools that can be applied to enhance early detection and imp…